Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease
- PMID: 7701249
- DOI: 10.3109/00365529509093234
Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease
Abstract
Background: omega-Oxidation is regarded as the major pathway for leukotriene B4 (LTB4) metabolism. Very little is known about it in colonic mucosa with inflammatory bowel disease (IBD).
Methods: We investigated the metabolic ratio of omega-oxidation to LTB4 biosynthesis in colonic mucosa from patients with IBD and control subjects. After incubation of colonic mucosa with 14C-arachidonic acid and ionophore A23187, we separated LTB4 and its omega-oxidative metabolites by high-performance liquid chromatography.
Results: The rate of LTB4 omega-oxidation was comparable to the rate of its biosynthesis. The metabolic ratio was significantly decreased in inflamed mucosa with ulcerative colitis.
Conclusions: LTB4 omega-hydroxylase activity is an important factor in regulating LTB4 level in colonic mucosa, and the increased LTB4 level in inflamed mucosa with IBD, especially ulcerative colitis, is caused by decreased LTB4 omega-hydroxylase activity and increased 5-lipoxygenase activity.
Similar articles
-
Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.Gastroenterology. 1984 Mar;86(3):453-60. Gastroenterology. 1984. PMID: 6319219
-
Leukotriene B4 omega-hydroxylase activity in polymorphonuclear leukocytes from patients with inflammatory bowel disease.Prostaglandins Leukot Essent Fatty Acids. 1993 Jul;49(1):489-94. doi: 10.1016/0952-3278(93)90036-v. Prostaglandins Leukot Essent Fatty Acids. 1993. PMID: 8395694
-
Colorectal leukotriene B4 synthesis in vitro in inflammatory bowel disease: inhibition by the selective 5-lipoxygenase inhibitor BWA4C.Gut. 1992 Apr;33(4):513-7. doi: 10.1136/gut.33.4.513. Gut. 1992. PMID: 1316305 Free PMC article.
-
Role of eicosanoids as mediators of inflammation in inflammatory bowel disease.Scand J Gastroenterol Suppl. 1990;172:13-8. doi: 10.3109/00365529009091903. Scand J Gastroenterol Suppl. 1990. PMID: 1972294 Review.
-
Leukotriene B4 in the immune system.Int J Immunopharmacol. 1992 Apr;14(3):441-9. doi: 10.1016/0192-0561(92)90174-j. Int J Immunopharmacol. 1992. PMID: 1319964 Review.
Cited by
-
Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology.PLoS One. 2013 Oct 18;8(10):e76532. doi: 10.1371/journal.pone.0076532. eCollection 2013. PLoS One. 2013. PMID: 24204637 Free PMC article.
-
Boswellia serrata: an overall assessment of in vitro, preclinical, pharmacokinetic and clinical data.Clin Pharmacokinet. 2011 Jun;50(6):349-69. doi: 10.2165/11586800-000000000-00000. Clin Pharmacokinet. 2011. PMID: 21553931 Review.
-
Involvement of Proinflammatory Arachidonic Acid (ARA) Derivatives in Crohn's Disease (CD) and Ulcerative Colitis (UC).J Clin Med. 2022 Mar 27;11(7):1861. doi: 10.3390/jcm11071861. J Clin Med. 2022. PMID: 35407469 Free PMC article.
-
Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.Inflamm Bowel Dis. 2017 Nov;23(11):1898-1904. doi: 10.1097/MIB.0000000000001236. Inflamm Bowel Dis. 2017. PMID: 28991856 Free PMC article.
-
Eicosanoids in the gastrointestinal tract.Br J Pharmacol. 2019 Apr;176(8):1000-1008. doi: 10.1111/bph.14178. Epub 2018 Apr 16. Br J Pharmacol. 2019. PMID: 29485681 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
